Since the last time an ABNM position statement was published in The Journal of Nuclear Medicine (J Nucl Med. 2003; 44:988-990) , there have been significant changes in the scope of nuclear medicine and in the residency training requirements. One major change has been the evolution of PET from a research methodology with limited clinical application to a routine diagnostic imaging method for evaluation of patients with malignant tumors or with cardiovascular or neurologic disease. Imaging with hybrid PET/CT scanners is now the standard for oncology indications. Although 18 F-FDG is the only oncologic PET radiopharmaceutical currently approved by the U.S. Food and Drug Administration, others will likely become available. Hybrid SPECT/CT has emerged in parallel with PET/CT and is being rapidly incorporated into diagnostic imaging protocols. Hybrid PET/MRI is under development and may soon be deployed in the clinical setting.
An additional change has been the way in which a physician's competence is viewed. In the past, the board's efforts were focused primarily on assessing the medical knowledge of trainees and diplomates. The evolutionary changes in the practice of nuclear medicine, like all medical specialties, require that all diplomates be engaged in systematic lifelong learning that is credible to the public. The ABNM is no longer merely a specialty certification board that determines the competencies of physicians at the time that they complete their training. Lifetime certificates and even 10-y certifications with recertification are a thing of the past. Lifelong learning must now be documented annually as defined by the ABMS-mandated Maintenance of Certification (MOC) requirements.
The mandated ABMS MOC program consists of 4 parts:
I. Professional standing. The ABNM now automatically receives a report of all disciplinary actions taken by state medical licensing boards, reviews these actions, and formulates an appropriate response according to the severity of the offense. II. Lifelong learning and self-assessment. The ABNM now monitors continuing medical education activities. Self-assessment activities are now required for continuing medical education. III. Cognitive expertise. The ABNM certification and MOC examination are now computer-based and are given at over 200 centers in the United States and around the world. IV. Practice performance assessment. Diplomates are now required to participate in quality improvement activities that involve data from their own practices.
All recent diplomates (since 1992) are required to participate in MOC to maintain their certificates. Diplomates with lifetime certificates are expected to participate.
The concepts of molecular imaging and therapy are guiding our vision of the future. Nuclear medicine is defined by the core knowledge required to apply the tracer principle to study physiologic, biochemical, and molecular processes in humans; it is not defined merely by the technical aspects of how the signal of interest is detected. Molecular imaging, with and without radioactive tracers, is central to how nuclear medicine is practiced today and how it will be practiced in the future.
Therapy using radiopharmaceuticals has always been an important part of nuclear medicine and will likely increase over time because of advances in targeted therapy using radioimmunotherapy and radiopeptides. For example, since the 2003 position statement, therapy for non-Hodgkin jnm089979-sn n 5/6/11 lymphoma using 90 Y-or 131 I-labeled monoclonal antibodies has become a routine part of many clinical practices. Treatment of liver metastasis with 90 Y-microsphere therapy (SIR-Spheres [Sirtex] or TheraSphere [Nordion] ) is also Food and Drug Administration-approved, and its clinical use is growing.
In July 2007, the Nuclear Medicine Residency Review Committee of the American College of Graduate Medical Education (ACGME) implemented revised training requirements that increased residency length from 2 to 3 y (not including the required preparatory clinical year) in response to the expanding scope and increased knowledge required for nuclear medicine practice. Because hybrid-imaging devices have become standard, nuclear medicine physicians now must be knowledgeable about 3-dimensional anatomy and the interpretation of these images.
SCOPE OF NUCLEAR MEDICINE SPECIALIST PRACTICE
On the basis of training and experience, ABNM nuclear medicine specialists are expert in all aspects of diagnostic and therapeutic nuclear medicine services. They are qualified to interpret the entire range of diagnostic studies, including single-photon and positron-emitter radiopharmaceutical distributions obtained with planar and tomographic techniques and, when appropriate, hybrid tomographic data including coregistered anatomic (CT) and radiotracer (PET or SPECT) images. ABNM nuclear medicine specialists are sufficiently expert to serve as directors of nuclear imaging laboratories, with responsibility for establishing and reviewing imaging procedural protocols, supervising other nonspecialist nuclear image interpreting practitioners, and establishing and reviewing laboratory and physician quality metrics. They are competent to perform all radiopharmaceutical therapies. Specialist practitioners devote a substantial fraction of their clinical practice to nuclear medicine to maintain broad competency in diagnostic and therapeutic radionuclide procedures. It is expected that a substantial portion of their ABMS-mandated MOC will be devoted to nuclear medicine and closely related areas of practice.
Physicians completing a training path resulting in eligibility for ABNM certification are qualified nuclear medicine specialist practitioners. Current training requirements include any of the following 3 alternatives: a minimum of 12 mo in an ACGME-accredited nuclear medicine residency after completion of a 4-y diagnostic radiology residency (a total of 16 mo of dedicated nuclear medicine training), a minimum of 24 mo in an ACGME-accredited nuclear medicine residency after completion of another ACGME residency (e.g., internal medicine, surgery, or neurology), or a minimum of 36 mo in an ACGME-accredited nuclear medicine residency after completion of a preparatory postgraduate clinical year. A proposed 4-y combined diagnostic radiology and nuclear medicine residency (which includes 16 mo of dedicated nuclear medicine training) will also result in eligibility for ABNM certification.
NUCLEAR MEDICINE CORE COMPETENCY AREAS
The nuclear medicine physician is a physician first and foremost. a. Production of radionuclides by reactors, cyclotrons, and other particle accelerators and the use of radionuclide generators. b. Formulation and labeling of radiotracers; quality control procedures, including sterility and apyrogenicity; and familiarity with good manufacturing practice. c. Biochemistry, physiology, molecular biology, and pharmacokinetics of radiotracers and mechanisms of localization in normal and abnormal physiologic states. d. Role of regulatory bodies and regulations applicable to the use of radiotracers and other tracers in nuclear medicine practice and research. VII. In vivo diagnostic use of radiopharmaceuticals and other tracers. a. In vivo imaging or body function measurements of the central nervous system, endocrine system, salivary glands, bone marrow and hematologic system, respiratory system, cardiovascular system, gastrointestinal tract, hepatobiliary system, lymphatic system and spleen, musculoskeletal system, and genitourinary system and multiorgan oncologic imaging. b. Use of imaging for quantification of physiologic functions such as renal clearance, gastric emptying, and cardiac and gallbladder ejection fraction. c. Kinetics, absorption, excretion, and dilution analyses using radiopharmaceuticals and other tracers.
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SUMMARY
This document is not meant to be an all-inclusive list of everything that encompasses the field of nuclear medicine, which is ever changing, nor is it a list of topics and knowledge required to pass a certification or MOC examination. Nuclear medicine program requirements and the ABNM examination content manual are available on the ACGME Web site (http:// www.acgme.org/acWebsite/RRC_200/200_prIndex.asp) and the ABNM Web site (http://www.abnm.org/contmanual.pdf), respectively. New requirements for ACGME nuclear medicine program residency go into effect on July 1, 2011. The ABNM uses these as reference guides; however, the ABNM examinations are written by the 12 experts who make up the ABNM and have years of different experiences in academic and community practices. To take the certification examination, the physician's program director must first document that a resident has successfully completed the residency training. The certification examination emphasizes basic science and the clinical knowledge and understanding acquired during residency that allow one to be prepared to competently practice nuclear medicine. The MOC examination is similar except that it emphasizes present-day clinical practice. Future MOC examinations may be modular so that practitioners can be tested in the areas of nuclear medicine that are most relevant to their clinical practice-for example, general nuclear medicine, hybrid imaging, cardiovascular nuclear medicine, and therapy.
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